She reached out because something didn’t make sense, and you could hear the frustration in how she described it. The initial responses had been strong, the conversations had started in the right direction, and there was a clear sense that the opportunity resonated with the companies she was contacting. Then, without any obvious reason, everything slowed down. Follow-ups went unanswered, conversations stalled, and what initially felt like momentum turned into silence.
What made this situation particularly interesting is that the intellectual property itself was not only real, but highly relevant to a known problem in healthcare. She had developed an alternative, parallel coding system designed to fill the gaps in conventional medical insurance billing, specifically enabling integrative and alternative healthcare providers to properly code and bill insurance for services that are often not recognized within standard coding frameworks.
If you understand how fragmented billing can be in that space, you immediately see the value. Providers struggle to get reimbursed. Payers struggle to categorize services. Platforms struggle to standardize data. What she had built addressed all three.
On paper, it was exactly the kind of system that should generate licensing interest across healthcare organizations, software platforms, and insurance-related entities.
And initially, it did.
So the question wasn’t why companies weren’t interested.
The question was why they stopped engaging.
The IP Solved a Real Problem—But That Wasn’t Enough
As we reviewed her outreach, it became clear that the substance of what she had built was not the issue. The system had a strong use case, a defined market, and a clear role in solving a structural problem within healthcare billing. It wasn’t abstract or theoretical. It was practical and applicable.
The challenge was how that value was being introduced in the first interaction.
Her messaging explained the system in detail. It described how the coding structure worked, how it could be implemented, and how it could evolve over time as part of a broader healthcare ecosystem. From a technical standpoint, it was accurate and well thought out.
But it required the recipient to understand the system before understanding why it mattered to them.
And that’s where engagement breaks down.
What the Market Was Actually Listening For
When a company receives a licensing outreach message, especially in a complex and regulated space like healthcare, they are not immediately trying to understand the full architecture of what you’ve built. They are filtering quickly based on whether the opportunity connects to something they already care about.
In this case, the companies she was reaching out to were asking themselves whether this would impact reimbursement, whether it could create new billing pathways, and whether it would integrate into their existing systems without disrupting operations.
Those are the entry-point questions.
If the message doesn’t answer those quickly and clearly, the opportunity gets set aside, even if the underlying value is significant.
Why Interest Didn’t Turn Into Ongoing Conversations
Her outreach was strong enough to generate initial curiosity, which is why she received early responses. The concept made sense, and the problem it addressed was recognized. But the messaging did not clearly translate that into immediate relevance for the recipient.
There is a difference between recognizing that something is valuable and understanding why it matters to you right now.
That gap is where most licensing conversations stall.
Companies don’t respond with a rejection. They simply don’t continue the conversation, because the effort required to fully understand the opportunity outweighs the immediate clarity of its impact.
What We Changed in the Positioning
Instead of leading with how the system worked, we shifted the focus to what it enabled.
We reframed the outreach to highlight how this parallel coding system could allow providers to bill for services that are currently under-coded or not coded at all, how it could open new reimbursement pathways, and how it could be layered into existing billing and software systems without requiring a complete overhaul.
That shift may sound simple, but it changes how the opportunity is received.
Now, instead of asking the recipient to understand the system, we are showing them where it fits into a problem they already recognize.
The Impact of That Shift
Once the messaging was repositioned, the nature of the responses changed.
Companies began asking how the system could be implemented within their platforms, how it would align with existing billing processes, and what the pathway to integration would look like. The conversation moved from curiosity to application, which is where licensing discussions begin to take shape.
The IP didn’t change.
The market didn’t change.
What changed was how the opportunity was framed at the very beginning.
Why This Happens So Often
When someone has built something meaningful, especially in a complex space like healthcare, there is a natural tendency to explain it thoroughly. You want the other side to understand the full scope of what you’ve created, because that’s where the value lives.
But licensing conversations don’t start at full understanding.
They start with relevance.
If the relevance is not immediately clear, the conversation doesn’t last long enough for the deeper value to be explored.
Understanding that sequence is critical.
Where LCG Adds Value
This is exactly where we work with clients at Licensing Consulting Group, because this is often the difference between opportunities that gain traction and those that stall early. We help translate complex intellectual property into clear, market-relevant positioning that aligns with how licensees evaluate new opportunities.
That includes refining messaging, identifying the right targets, and structuring outreach so that it creates engagement rather than requiring interpretation. From there, we guide the process through ongoing communication, negotiation, and deal development, ensuring that the opportunity continues to move forward.
Your Next Step
If you’re reaching out to potential licensees and not getting the level of engagement you expected, or if conversations are starting but not progressing, it’s worth taking a closer look at how your opportunity is being positioned at the first point of contact.
👉 Schedule a 15-minute strategy call:
https://calendly.com/licensingcg/15-minute-video-meeting
We’ll review your current outreach, identify where the disconnect is happening, and help you reposition your opportunity so that companies clearly understand why it matters to them.
Stay Connected
If you want more insights into how licensing outreach actually works and what drives engagement in real conversations, you can sign up for the Licensing Consulting Group newsletter. We share real-world examples, practical strategies, and insights that help you move from initial interest to meaningful licensing discussions.
The interest was there from the beginning.
What changed was whether the companies could immediately see why it mattered to them.
Rand Brenner is an IP professional whose passion is helping inventors, startups, and businesses use licensing to turn their IP into income-producing products, services, and technologies. His decades of experience run the gamut from medical devices to food technology to consumer products. He’s licensed some of the biggest Hollywood entertainment blockbusters, including the Batman Movies (1 and 2) and the number one kid’s action TV show, the Mighty Morphin Power Rangers. Rand speaks about licensing and is a featured speaker at investment conferences, trade shows, colleges, and startup events. His first book, Hidden Wealth: The Money-Making Power of Licensing, was released in 2019 and is available on Amazon.com. He’s also a published writer, and his articles have appeared in several prestigious trade magazines, including The Licensing Journal, Intellectual Property Magazine, and License India.
Working Through a Licensing or Commercialization Challenge?
If you have market-ready intellectual property, a licensing campaign that has stalled, or a business opportunity that may benefit from licensing, a short strategy discussion can help clarify the next step.